| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |